Related references
Note: Only part of the references are listed.Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF
Joao Pedro Ferreira et al.
JACC-HEART FAILURE (2021)
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2021)
Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans
Lingling Ding et al.
DIABETOLOGIA (2020)
The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
Martijn F. Hoes et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial
Pierpaolo Pellicori et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
GDF15 mediates the effects of metformin on body weight and energy balance
Anthony P. Coll et al.
NATURE (2020)
Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
Jasper Tromp et al.
JACC-HEART FAILURE (2020)
Circulating adhesion molecules and associations withHbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study
Jeanie B. Tryggestad et al.
PEDIATRIC DIABETES (2020)
IL1R1 is required for celastrol's leptin-sensitization and antiobesity effects
Xudong Feng et al.
NATURE MEDICINE (2019)
In search of causal pathways in diabetes: a study using proteomics and genotyping data from a cross-sectional study
Kristina Beijer et al.
DIABETOLOGIA (2019)
Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes-The Malmo Preventive Project
John Molvin et al.
SCIENTIFIC REPORTS (2019)
Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss
Emily A. Day et al.
NATURE METABOLISM (2019)
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure Insights From the HF-ACTION Study
Abhinav Sharma et al.
JACC-HEART FAILURE (2017)
Correlation of E-selectin concentrations with carotid intima-media thickness and cardio-metabolic profile of mixed ancestry South Africans: a cross-sectional study
Annalise E. Zemlin et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction
Junli Liu et al.
CELL (2016)
Usefulness of Growth Differentiation Factor-15 Levels to Predict Diabetic Cardiomyopathy in Asymptomatic Patients With Type 2 Diabetes Mellitus
Alberto Dominguez-Rodriguez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Adipocyte Inflammation Is Essential for Healthy Adipose Tissue Expansion and Remodeling
Ingrid Wernstedt Asterholm et al.
CELL METABOLISM (2014)
Lysosomal Cathepsin D contributes to cell death during adipocyte hypertrophy
Akiko Eguchi et al.
ADIPOCYTE (2013)
PGRN is a Key Adipokine Mediating High Fat Diet-Induced Insulin Resistance and Obesity through IL-6 in Adipose Tissue
Toshiya Matsubara et al.
CELL METABOLISM (2012)
Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure
Masayuki Yamaji et al.
AMERICAN HEART JOURNAL (2010)
Spironolactone impairs endothelial function and heart rate variability in patients with Type 2 diabetes
JI Davies et al.
DIABETOLOGIA (2004)
The effect of diabetes on outcomes of patients with advanced-heart failure in the BEST trial
M Domanski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Share Paper
